ϩ extrusion is important for sustained NADPH oxidase activation after "respiratory" burst in macrophage/microglia activation. In this study, we investigated the role of Na 
Introduction
Microglial cells are ubiquitously distributed throughout the CNS and serve as neuropathological sensor under conditions such as peripheral nerve injury, trauma and stroke, inflammatory disease, and neurotoxin-induced neuronal injury (Hanisch and Kettenmann, 2007; Chen et al., 2009; Neumann et al., 2009 ). Microglial activation is associated with morphological changes, proliferation, motility, phagocytosis, and release of reactive oxygen species (ROS), nitrogen species, interleukins, cytokines, and chemokines (Harrigan et al., 2008; Boscia et al., 2009 ). The NADPH oxidase (NOX)-dependent ROS generation plays a crucial role in host defense to counteract and kill invading microbes, as well as in other physiological functions (Bedard and Krause, 2007) . Conversely, ROS liberated by microglial respiratory burst may play an important role in numerous neurodegenerative processes.
The primary source of ROS production in microglia is through NOX that catalyzes the reduction of molecular oxygen to superoxide anion (O 2 ⅐ Ϫ ) using NADPH as an electron donor (Bedard and Krause, 2007; Harrigan et al., 2008) . In this process, H ϩ accumulates inside microglia, causing depolarization and cytoplasmic acidification (De Vito, 2006) . NOX activity is markedly sensitive to intracellular pH (pH i ) with an optimal pH i of 7.2 (Henderson et al., 1988) . Cytoplasmic acidification may impair O 2 ⅐ Ϫ production as a result of inhibition of NOX (Swallow et al., 1993) . Therefore, maintaining physiological pH i is critical for respiratory burst activity in microglia. However, the cellular and molecular mechanisms underlying the H ϩ regulation in microglia are not well defined. Na ϩ /H ϩ exchanger isoform 1 (NHE-1) is a ubiquitously expressed plasma membrane protein and the most abundant NHE isoform in the CNS (Ma and Haddad, 1997) . NHE-1 protects cells from internal acidification by exchanging Na ϩ for H ϩ in an electroneutral manner (Luo et al., 2005) . Na ϩ /H ϩ exchangemediated H ϩ extrusion contributes to the pH i recovery of acidloaded peritoneal macrophages (Rotstein et al., 1987) and alveolar macrophages after osmotic cell shrinkage (Heming and Bidani, 1995) . However, to date, no information is available on NHE-1 protein expression in microglia and its role in activation of microglia. In this study, we report that NHE-1 is involved in maintaining pH i homeostasis in microglia. Microglial activation via lipopolysaccharide (LPS), phorbol myristate acetate (PMA), or in vitro ischemia stimulates NHE-1 activity.
Materials and Methods
Materials. HBSS and L-glutamine were from Mediatech Cellgro. Fura-2 AM, 2Ј,7Ј-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein (BCECF) AM, sodium-binding benzofuran isophthalate (SBFI) AM, calcein AM, isolectin GS-IB 4 (Alexa Fluor 488 conjugate), dihydroethidium (DHE), 4-bromo A-23187 (4-bromo-calcimycin), DMEM, and versene were from Invitrogen. Diphenylene iodonium (DPI), LPS, PMA, DMEM/F-12, and nigericin were purchased from Sigma. Bafilomycin was from Tocris Bioscience. Pluronic F-127 was from BASF Corp. HOE 642 (4-isopropyl-3-methylsulfonyl-benzoyl-guanidine-methanesulfonate) was a kind gift from Aventis Pharma. Fetal bovine serum (FBS) was obtained from Valley Biomedical. Rabbit anti-CD11b polyclonal antibody and rabbit anti-NHE-1 polyclonal antibody were purchased from Abcam. Rat anti-CD11b monoclonal antibody was purchased from AbD Serotec, and anti-␤ tubulin monoclonal antibody was from Promega. Goat polyclonal antibody to Iba1 and rabbit polyclonal antibody to NADPH oxidase 2 (NOX2) were purchased from Abcam.
Primary microglia culture. Isolation of mixed primary glial cultures from postnatal days 1 to 3 mouse brain was performed as described previously with minor modifications . Briefly, brains were removed from 1-to 3-d-old neonatal mice, and the meninges were removed. The left and right hemispheres of the brain were gently dissociated in a nylon mesh sterile cell strainer, and the resulting cell suspension was passed through stainless steel screens. The cells were resuspended in DMEM/F-12 complete medium supplemented with 5% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin (Invitrogen) and seeded in poly-D-lysine-coated T75 tissue culture flasks. The cultures were incubated at 37°C with 5% CO 2 /95% air and refed three times per week. After 10 -14 d of incubation, microglia were removed from the astroglial layer by shaking the flasks on an orbital shaker (Labnet model Orbit P4) for 1 h at 200 rpm in the incubator. After the shaking, the collected medium was centrifuged at 300 ϫ g for 10 min at 4°C. The microglia pellets were gently resuspended in the microglial medium (DMEM supplemented with 10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin) and seeded on the poly-D-lysine-coated 15-mmround glass coverslips in 24-well plates (4 -5 ϫ 10 5 cells per well). Experiments were performed on day 1-3 after seeding.
M4T.4 microglia cell line culture. The M4T.4 cells were derived from simian virus 40 large T-antigen-immortalized microglia isolated from SJL/J mice (Olson et al., 2003) . Normally, the M4T.4 cells are quiescent but can be induced to release proinflammatory cytokines in response to stimuli (Olson et al., 2003) . The immune response in M4T.4 cells is similar to the response in primary microglial cultures after exposure to interferon-␥ and virus infection (Olson et al., 2003) . In brief, M4T.4 cells were cultured in poly-D-lysine-coated T25 flasks in DMEM supplemented with 10% FBS, 2 mM L-glutamine, and recombinant mouse granulocyte-macrophage colony-stimulating factor (GMCSF). M4T.4 cells were maintained in poly-D-lysine-coated flasks with microglia medium at 37°C with 5% CO 2 /95% air and were split (1:4) every 2 d by gently removing the cells with versene. M4T.4 cells were seeded on the poly-D-lysine-coated 22 ϫ 22 mm glass coverslips in six-well plates (1 ϫ 10 5 cells per well). Cultures of passage 18 or lower were used in this study.
Oxygen and glucose deprivation, LPS, and PMA treatments. Microglia cultures grown on coverslips were rinsed with an isotonic oxygen and glucose deprivation (OGD) solution, pH 7.4, containing the following (in mM): 0 glucose, 21 NaHCO 3 , 120 NaCl, 5.36 KCl, 0.33 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 1.27 CaCl 2 , and 0.81 MgSO 4 . The cells were incubated in 1 ml of OGD solution for 2 h in a hypoxic incubator (model 3130; Thermo Forma) containing 94% N 2 , 1% O 2 , and 5% CO 2 . Normoxic control cells were incubated for 2 h in 5% CO 2 and atmospheric air in a buffer identical to the OGD solution except for the addition of 5.5 mM glucose. Reoxygenation (REOX) was achieved by addition of glucose (5.5 mM) and incubation at 37°C in 5% CO 2 and atmospheric air. Alternately, REOX was performed on the microscope stage by incubation in a nominally HCO 3 Ϫ -free HEPES buffer, pH 7.4, containing the following (in mM): 5.5 glucose, 137 NaCl, 5.36 KCl, 0.33 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 1.27 CaCl 2 , 0.81 MgSO 4 , and 20 HEPES.
For LPS treatment, microglial cultures were incubated with 100 -500 ng/ml LPS for 12-24 h at 37°C. For PMA treatment, microglia was exposed to 100 nM PMA for 10 -60 min.
Immunofluorescence staining. Microglia grown on coverslips were fixed in 4% paraformaldehyde in PBS for 15 min. After rinsing, cells were incubated with a blocking solution for 20 min, followed by application of rat anti-mouse CD11b monoclonal antibody (1:100 diluted in the blocking buffer), rabbit anti-NHE-1 polyclonal antibody (1:100 diluted in the blocking buffer), or rabbit anti-NOX2 polyclonal antibody (1:100 diluted in the blocking buffer) at 4°C overnight. After rinsing in PBS, cells were incubated with goat anti-rat secondary antibody IgG (heavy and light chain) conjugated to Alexa Fluor 488 (1:200 dilution) and goat anti-rabbit secondary antibody IgG (heavy and light chain) conjugated to Alexa Fluor 546 (1:200 dilution) for 1 h at 37°C. Fluorescence images were captured with a Leica DMIRE2 inverted confocal laser-scanning microscope (40ϫ oil-immersion objective).
Immunoblotting. M4T.4 cells were scraped from the flasks and lysed in PBS, pH 7.4, containing 2 mM EDTA and protease inhibitors by 30 s sonication at 4°C (Luo et al., 2005) . Protein content was determined by the bicinchoninic acid method. Protein samples (60 g/lane) and prestained molecular mass markers (Bio-Rad) were denatured in SDS 5ϫ sample buffer and then electrophoretically separated on 8% SDS gels. After transferring to a nitrocellulose membrane, the blots were incubated in 5% nonfat dry milk in Tris-buffered saline for 2 h at room temperature and then incubated with rabbit anti-CD11b polyclonal antibody (1:440), rabbit anti-NHE-1 polyclonal antibody (1:1000), goat anti-Iba1 polyclonal antibody (1:500), or rabbit anti-NOX2 polyclonal antibody (1: 1000) overnight at 4°C, respectively. After rinsing, the blots were incubated with horseradish peroxidase-conjugated secondary IgG at room temperature for 1.5 h. Bound antibody was visualized using the enhanced chemiluminescence assay (GE Healthcare).
Staining of microglia with isolectin IB 4 . Primary microglia grown on coverslips were stained with isolectin IB 4 (50 g/ml) conjugated to Alexa Fluor 488 in a humidified chamber at 37°for 30 min. The coverslip was then placed in a perfusion chamber on the stage of the Leica DMIRE2 confocal microscope at 37°C. Microglia were visualized with a 60ϫ oilimmersion objective, and images from 512 ϫ 512 scans were collected (excitation, 488 nm argon laser line; emission, 500 -545 nm). pH i measurement. pH i measurement and prepulse treatment were performed as described previously (Luo et al., 2007) . Briefly, microglia cultures grown on coverslips were incubated with 1.3-2.5 M BCECF AM at 37°C for 30 min. The coverslips were placed in a temperature-controlled (37°C) open-bath imaging chamber containing HCO 3 Ϫ -free HEPES-MEM (model RC24; Warner Instruments). The chamber was mounted on the stage of the Nikon TE 300 inverted epifluorescence microscope, and the cells were visualized with a 40ϫ objective. The cells were excited every 10 -30 s at 440 and 490 nm, and the emission fluorescence at 535 nm was recorded. Images were collected using a Princeton Instruments MicroMax CCD camera and analyzed with MetaFluor (Molecular Devices) image-processing software. The ratio of the background-corrected fluorescence emissions (F 490 /F 440 ) was calibrated using the high K ϩ / nigericin technique (Boyarsky et al., 1993) .
For the prepulse treatment, cells were subjected to an acid load by a transient application (5 min) of a 30 mM NH 4 ϩ /NH 3 solution as described previously (Luo et al., 2007) . NH 4 ϩ /NH 3 solutions were prepared by replacing 30 mM NaCl in the HCO 3 Ϫ -free, HEPES-buffered solution with an equimolar concentration of NH 4 Cl. pH i recovery rate during the first minute after NH 4 ϩ /NH 3 prepulse was determined from the slope of a fitted linear regression at pH 6.5 .
For examining HCO 3 Ϫ -dependent transporters in pH i regulation, cells were superfused with a solution containing 21 mM HCO 3 Ϫ /5 mM HEPES bubbled with 5% CO 2 .
Intracellular Ca 2ϩ measurement. Microglia grown on coverslips were incubated with 5 M fura-2 AM at 37°C for 30 min under either normoxic conditions or during the last 30 min REOX after 2 h OGD. After loading, the cells were placed in the open-bath imaging chamber and superfused with HCO 3 Ϫ /MEM at 37°C. Using the Nikon TE 300 inverted epifluorescence microscope and a 40ϫ objective lens, cells were excited every 10 -30 s at 345 and 385 nm, and the emission fluorescence at 510 nm was recorded. Images were collected for 2-5 min to determine Ca 2ϩ levels and analyzed with the MetaFluor image-processing software. At the end of each experiment, the cells were exposed to 1 mM MnCl 2 in Ca 2ϩ -free HCO 3 Ϫ /MEM and 5 M 4-bromo A-23187. The Ca 2ϩ -insensitive fluorescence was subtracted, and the MnCl 2 -corrected 345/ 2ϩ concentration as described previously .
Intracellular Na ϩ measurement. Intracellular Na ϩ concentration ([Na ϩ ] i ) was measured in microglia with the fluorescent dye SBFI AM as described previously . Cultured cells grown on coverslips were loaded with 10 M SBFI AM plus 0.02% pluronic acid at 37°C for 60 min (normoxia or REOX). The coverslips were placed in the open-bath imaging chamber and superfused (1 ml/min) with HCO 3 Ϫ / MEM at 37°C. Using the Nikon TE 300 inverted epifluorescence microscope and a 40ϫ lens, cells were excited at 345 and 385 nm, and the emission fluorescence at 510 nm was recorded. Images were collected for 2-5 min to determine Na ϩ levels, and the 345/385 ratios were analyzed with the MetaFluor image-processing software. Absolute [Na ϩ ] i was determined for each cell by performing an in situ calibration as described previously (Su et al., 2002) .
Detection of superoxide production. First, O 2 ⅐ Ϫ production was estimated by the fluorescent dye DHE. DHE can react with intracellular O 2 ⅐ Ϫ and is oxidized to the red fluorescent compound ethidium, which binds irreversibly to double-stranded DNA in the nucleus (Zhao et al., 2003) . Cultured microglia grown on coverslips were loaded with 5 M DHE for 15 min before 2 h OGD. The coverslips were placed in an open-bath imaging chamber (37°C) in HCO 3 Ϫ -free HEPES/MEM. The cells were excited at 560 nm, and the emission fluorescence at 640 nm was recorded every 10 min for 1 h using Nikon TE 300 inverted epifluorescence microscope and MetaMorph image-processing software (Molecular Devices).
In parallel, O 2 ⅐ Ϫ production by microglia was also determined using the Diogenes System (National Diagnostics) according to the directions of the manufacturer. Diogenes is a O 2 ⅐ Ϫ chemiluminescence enhancer that produces light in a direct proportion to O 2 ⅐ Ϫ concentration. Briefly, either primary microglia or M4T.4 were grown on 96-well white nunclon plates. Cells were subjected to the following treatments: normoxia, 2 h OGD plus 1 h REOX, or 100 nM PMA for 10 min. At the end of the incubations, the medium was removed and replaced with Diogenes solution. Luminescence in the culture was integrated over 10 s using Luminometer (LMax II; Molecular Devices). Total cellular protein was determined in each well with the bicinchoninic acid method. O 2 ⅐ Ϫ concentration was expressed as relative light units (RLU) per microgram protein. For the PMA experiments, luminescence in the culture was determined at 0, 1, 5, and 10 min after adding 100 nM PMA. The RLU per seconds per micrograms protein values were normalized to the untreated control values.
Measurements of cytokine mRNA and NOS2 mRNA. M4T.4 microglia were subjected to 2 h OGD plus 24 h REOX or 500 ng/ml LPS treatment for 24 h. At the end of each treatment, the cells were pelleted and total RNA was isolated from the cells using SV Total RNA Isolation kit (Promega). First-strand cDNA was generated from 1 g of total RNA from the microglia using Advantage RT-for-PCR kit with oligo-dT 12-18 primers in a final volume of 100 l (Clontech Laboratories). Real-time PCR reactions were conducted with Faststart SYBR Green Master Mix (Roche Molecular Biochemicals). Briefly, 0.5 M primers, 2 mM MgCl 2 , 1ϫ FastStart SYBR Green Master mix, and 2 l of diluted cDNA were used. The primers were synthesized by Invitrogen: interleukin-1␤ (IL-1␤) (5ЈTGAATGCCATTTTGACA3Ј, 5ЈGTAGCTGCCACAGCT-TCTCC3Ј), IL-6 (5ЈTTCCATCCAGTTGCCTTCTT3Ј, 5ЈCAGAATT-GCCATTGCACAAC3Ј), tumor necrosis factor ␣ (TNF-␣) (5ЈCTGT-GAAGGGAATGGGTGTT3Ј, 5ЈGGTCACTGTCCCAGCATCTT3Ј), and NOS2 (5ЈCTCACTGGGACAGCACAGAA3Ј, 5ЈTGGTCAAACTCTT-GGGGTTC3Ј). Real-time PCR was conducted on Rotorgene 6000 (Qiagen) using hot start with cycle conditions, 40 cycles: 95°C for 15 s, 60°C for 2 s, and 72°C for 15 s, followed by a melt from 75 to 95°C, and a final 72°C extension for 5 min. Quantitation of the mRNA was based on standard curves derived from cDNA standards for each primer set. Positive and negative cDNA controls were used for each primer set derived from known cell sources for each cytokine. The fold increase was determined based on the mRNA expression of control cells for each condition. Significant increase in mRNA expression for treated cells was based on at least a twofold increase over the controls. Significant difference between untreated and treated cells was determined using the Student's t test.
Cytokine measurement. M4T.4 microglia were subjected to 2 h OGD plus 24 h REOX or 500 ng/ml LPS treatment for 24 h. Culture medium was collected and assayed for cytokine secretion using Bio-Plex Pro mouse 4 cytokine kit (Bio-Rad), as per the instructions of the manufacturer. Briefly, after prewetting the wells of a porous, flat-bottom 96-well filter microplate with wash buffer, 2500 coupled beads were added per well and washed by vacuum filtration with wash buffer. Coupled beads were incubated with culture medium samples (50 l/well) for 30 min at room temperature in the dark with agitation. After washing twice with wash buffer, the beads were incubated with 0.8 g of detection antibody in 50 l of assay diluant for 30 min at room temperature in the dark with agitation. After washing, the beads were incubated with 100 ng of phycoerythrin (50 l/well) for 10 min at room temperature in the dark with agitation. The beads were analyzed on Bio-Plex analyzer (Bio-Rad), and the cytokines were quantified based on a set of standards for the assay. Total cellular protein in each well was determined with the bicinchoninic acid method. Cytokine concentration was expressed as picograms per milligrams protein.
Results

Expression of NHE-1 in M4T.4 immortalized microglia and primary microglia
CD11b is expressed in immortalized M4T.4 microglia and primary microglia cells. Abundant NHE-1 protein expression was localized in both cell body and processes of microglia with a "ramified" morphology ( Fig. 1 A) . Colocalization of NHE-1 and CD11b was found in M4T.4 and primary microglia cells (Fig. 1 A,  overlay) . The NHE-1 protein remained abundant in microglia (either M4T.4 or primary) with the "amoeboid" morphology after LPS-mediated activation (100 ng/ml LPS for 12 h).
NHE-1 and CD11b protein expression in M4T.4 microglia was also shown by immunoblotting (Fig. 1 B) . NHE-1 protein band (ϳ100 kDa) was detected in both control and LPS-treated cells. M4T.4 cells exhibited abundant microglial marker proteins CD11b, Iba1, and NOX2 under control conditions and after the LPS treatment (Fig. 1 B) . Protein loading control was shown with similar levels of ␤-tubulin or actin expressed in each sample. Moreover, NOX2 protein expression in primary microglia was demonstrated by immunostaining (Fig. 1C) .
NHE-1 maintains basal pH i in M4T.4 microglia and primary microglia
Changes of pH i in M4T.4 microglia were determined by the H ϩ -sensitive dye BCECF. The selective and potent NHE-1 inhibitor HOE 642 (IC 50 of 0.08 M) was used to inhibit NHE-1 activity (Scholz et al., 1995) . As shown in Figure 2 A, M4T.4 microglia exhibited a basal pH i of 7.19 Ϯ 0.03 in a HCO 3 Ϫ -free HEPES/ MEM solution. When NHE-1 activity was inhibited by HOE 642, the basal pH i decreased to 6.82 Ϯ 0.02 in the absence of HCO 3 Ϫ ( p Ͻ 0.05). Interestingly, resting pH i was unchanged in the presence of 21 mM HCO 3 Ϫ (7.23 Ϯ 0.02). Inhibition of NHE-1 activity significantly reduced the basal pH i in the presence of HCO 3 Ϫ (7.03 Ϯ 0.02, p Ͻ 0.05) (Fig. 2 A) . These data suggest that NHE-1 plays a role in regulating basal pH i of M4T.4 microglia.
To investigate the role of NHE-1 in pH i regulation after acidosis, M4T.4 microglia were exposed to 30 mM NH 3 /NH 4 ϩ for 5 min. pH i rose rapidly to ϳ8.5 as NH 3 diffused into the cells and combined with H ϩ to form NH 4 ϩ (Fig. 2 Ba,Bb), and pH i declined slowly to ϳ7.5 with time ( Fig. 2 Bb,Bc) . As the cells were returned to the standard HCO 3 Ϫ -free HEPES/MEM solution, pH i dropped sharply to ϳ6 as a result of the newly formed NH 4 rapidly leaving cells as NH 3 , trapping H ϩ inside (Fig. 2Bc,Bd) . These are classical responses to the NH 3 /NH 4 ϩ prepulse. After this acid load-ing, M4T.4 microglia were able to restore pH i to their basal levels within 5 min (Fig. 2Bd ,Be) at an initial rate of ϳ0.38 pH/min. However, when the second NH 3 /NH 4 ϩ prepulse was repeated in the presence of NHE-1 inhibitor HOE 642 (Fig. 2Bf-Bi) , the pH i recovery in M4T.4 microglia was abolished (Fig. 2Bi,Bj) .
In the presence of a standard HCO 3 Ϫ -containing solution (21 mM), the pH i recovery rate was not significantly altered in M4T.4 microglia (Fig. 2B) . When NHE-1 was inhibited with 1 M HOE 642, the pH i recovery rate in M4T.4 microglia was blocked by 83% (Fig. 2B) . Together, these findings illustrate that NHE-1 activity dominates in regulation of pH i in M4T.4 microglia either in the absence or the presence of HCO 3 Ϫ . The HOE 642-insensitive pH i recovery may reflect HCO 3 Ϫ transporters (such as Na ϩ / HCO 3 Ϫ cotransporters), which play a minor role in pH i regulation.
Activation of microglia by LPS or PMA stimulates NHE-1 activity
We hypothesized that activation of microglia would result in excessive H ϩ production after stimulation of NOX, which would activate NHE-1 function. To test this hypothesis, we stimulated primary microglia with LPS or PMA. Primary microglia were abundantly labeled with isolectin IB 4 (Fig. 3A) . LPS stimulation (100 ng/ml for 24 h) produced the classical microglial morphology change (from "ramified" to "amoeboid") (Fig. 3B ). An alkaline pH i Bottom, Baseline pH i and pH i after 8 min of treatment with 1 M HOE 642 in the absence or presence of HCO 3 Ϫ . Data are mean Ϯ SEM. n ϭ 3-4. *p Ͻ 0.05 versus control (Con). B, Representative trace of pH i changes from a prepulse experiment in the presence or the absence of HOE 642 (1 M). Cells were exposed to 30 mM NH 4 Cl for 5 min (a-c) and then returned to standard HCO 3 Ϫ -free HEPES-buffered solution (c-e), and the pH i recovery was monitored (d, e). The prepulse was repeated in the presence of HOE 642 (f-h), and the pH i recovery was monitored (i, j). pH i recovery rate during the first minute after prepulse acidification was calculated. In the experiments, the solutions were supplemented with 21 mM HCO 3 Ϫ /5% CO 2 and 5 mM HEPES. Data are mean Ϯ SEM. n ϭ 5-6. *p Ͻ 0.05 versus control; # p Ͻ 0.05 versus HCO 3 Ϫ .
was detected in the LPS-treated microglia. This stimulation was accompanied with ϳ2.4-fold increase in pH i recovery rate (Fig. 3C) . Similarly, treatment of primary microglia with PMA (100 nM) for 60 min alkalized pH i and stimulated pH i recovery rate by 4.1-fold (Fig.  3C , p Ͻ 0.05). Most importantly, inhibition of NHE-1 activity by its potent inhibitor HOE 642 abolished this H ϩ extrusion triggered by either LPS or PMA treatment (Fig. 3C) . These data suggest that activation of microglia with LPS or PMA elevates NHE-1 activity and alkalinizes microglia. A similar observation was also made in M4T.4 microglia. As shown in Figure 3D , when M4T.4 microglia were exposed to 100 ng/ml LPS for 24 h, the pH i level increased to 7.29 Ϯ 0.02 (n ϭ 6, p Ͻ 0.05). The pH i recovery rates after the NH 3 /NH 4 ϩ prepulse were elevated by ϳ2.3-fold (Fig. 3D) . Moreover, inhibition of NHE-1 activity with HOE 642 significantly acidified M4T.4 microglia and nearly abolished pH i recovery capacity (Fig. 3D) . These data suggest that LPS stimulates H ϩ extrusion through activation of NHE-1 in M4T.4 microglia to maintain an optimal alkaline pH i for NOX function.
To determine whether NHE-1 functions in M4T.4 and primary microglia in a similar manner, we calculated the HOE 642-sensitive pH i regulation (Fig. 3E) . There was no difference in basal NHE-1 activity between the cell line and the primary cells. Moreover, NHE-1-mediated pH i regulation rate was significantly stimulated by LPS or OGD/REOX in both M4T.4 and primary microglia.
Activation of microglia with OGD/REOX stimulates NHE-1 activity M4T.4 microglia and primary microglia were stimulated by 2 h OGD and 60 min REOX. As shown in Figure 4 , A and B, M4T.4 microglia exhibited an alkaline pH i after OGD/REOX. The pH i recovery rate in the OGD/REOX-treated M4T.4 microglia was increased by ϳ2.4-fold, which allowed cells to restore pH i to their basal levels within 2 min after the NH 3 /NH 4 ϩ prepulse. In contrast, in the presence of 1.0 M HOE 642, M4T.4 microglia exhibited an acidic basal pH i and failed to regulate pH i after the NH 3 /NH 4 ϩ prepulse (Fig. 4 A, C) . Moreover, in the presence of the general NHE inhibitor ethylisopropylamiloride (EIPA) (100 M), M4T.4 microglia exhibited reduced basal pH i and failure to regulate pH i . In contrast, the vacuolar-type ATPase H ϩ pump inhibitor bafilomycin (1 M) had no effects on OGD/REOXmediated pH i alkalization or pH i recovery after the NH 4 ϩ Cl prepulse (Fig. 4 B, C) . This suggests that the vacuolar-type ATPase H ϩ pump is not involved in regulation of pH i in M4T.4 microglia. Thus, NHE-1 is the dominate NHE isoform regulating pH i after OGD/REOX.
We speculated that the NHE-1 activity-mediated pH i regulation was triggered by NOX activation and H ϩ production. To test this further, we investigated the effects of inhibition of NOX activity by DPI on NHE-1 function. It should be noted that DPI is a general inhibitor of electron transporters. It not only inhibits all NOX isoforms but also other electron transporters, such as nicotinamide adenine dinucleotide coenzyme Q reductase and nitric oxide synthase (Lambeth et al., 2008) . Interestingly, when DPI (1 M) was present during 60 min REOX, the OGD/REOXmediated stimulation of NHE-1 activity was reduced by ϳ50% at 60 min REOX (from 0.98 Ϯ 0.13 to 0.53 Ϯ 0.07 pH/min) (Fig. 4 B, C) . These findings further support our view that stimulation of NOX after OGD/REOX concurrently upregulates NHE-1 activity.
In primary microglia, OGD/REOX triggered an increase in the initial pH i recovery rate (0.37 Ϯ 0.05 vs 0.75 Ϯ 0.04 pH/min) (Fig. 4 D, G) . Primary microglia also exhibited a more alkaline pH i after 2 h OGD/60 min REOX. Inhibition of NHE-1 with HOE 642 or EIPA not only acidified the cell but also abolished the pH i recovery (Fig. 4 F, G) . Similar to M4T.4 cells, bafilomycin (1 M) did not affect the OGD/REOX-mediated changes in pH i or pH regulation (7.11 Ϯ 0.55 vs 7.14 Ϯ 0.04, p Ͼ 0.05) (Fig. 4 F, G) . # p Ͻ 0.05 versus untreated. E, HOE 642-sensitive pH i regulation was calculated under control, 2 h OGD/1 h REOX, or LPS conditions. Data are mean Ϯ SEM. n ϭ 6 -7. *p Ͻ 0.05 versus control.
Moreover, no changes of basal pH i were observed in primary microglia in the presence of HCO 3 Ϫ /CO 2 buffer (7.23 Ϯ 0.02 vs 7.24 Ϯ 0.02, p Ͼ 0.05). (Fig. 5A, arrow) . OGD/REOX resulted in an increase in [Na ϩ ] i (Fig. 5A, arrowhead) . Figure basal level of 12.4 Ϯ 0.4 to 28.6 Ϯ 1.2 or 33.1 Ϯ 1.9 mM, respectively, p Ͻ 0.05). Inhibition of NHE-1 with HOE 642 significantly reduced the Na ϩ overload in M4T.4 microglia induced by either LPS or OGD/REOX (Fig. 5 A, B) .
Elevation of [Na
We then examined whether activation of M4T.4 microglia triggered changes of [Ca 2ϩ ] i . Control [Ca 2ϩ ] i in M4T.4 microglia was 77 Ϯ 7 nM (Fig. 5C,D (Fig. 5C,D 
Superoxide anion production in activated microglia
We further investigated (1) whether OGD/REOX leads to O 2 ⅐ Ϫ production via NOX and (2) whether it depends on NHE-1 function. First, changes in DHE signals were examined. As shown in Figure 6 Aa, DHE signals were low in primary microglia under basal normoxic conditions (arrow). After 2 h OGD treatment, a few of the primary microglia exhibited increases in the nuclear DHE staining (arrowhead), whereas the remaining cells had a diffuse DHE staining pattern (Fig. 6 Ab). Interestingly, a timedependent increase in the nuclear DHE signals was detected at 60 min REOX (Fig. 6 Ac, arrowhead). In contrast, when HOE 642 (1 M) was present during 60 min REOX, the OGD/REOX-induced increase in the nuclear DHE signals was absent (Fig. 6 Ad).
To further evaluate NOX activity after OGD/REOX, we directly determined O 2 ⅐ Ϫ production using a chemiluminescence assay in primary microglia and M4T.4 cells. After 2 h OGD and 1 h REOX, O 2 ⅐ Ϫ production increased by ϳ17-fold in primary microglia and ϳ5-fold in M4T.4 cells (Fig. 6 B) . HOE 642 (1 M) treatment during 1 h REOX reduced O 2 ⅐ Ϫ production by ϳ50% in both the microglia cell line and the primary microglia.
As a positive control, we also stimulated primary microglia and M4T.4 cells with 100 nM PMA and monitored O 2 ⅐ Ϫ production within a 10 min period (Fig. 6C) . PMA caused a rapid increase in O 2 ⅐ Ϫ production by 1 min in primary microglia and reached a plateau level at 5 min in the presence of PMA (32.9 Ϯ 4.0 RLU/g). By 10 min PMA treatment, O 2 ⅐ Ϫ increased by 31.0 Ϯ 4.1-fold ( p Ͻ 0.05). Interestingly, inhibition of NHE-1 with 1 M HOE 642 during PMA stimulation reduced O 2 ⅐ Ϫ production by ϳ35% at 10 min (Fig. 6C) . In comparison, M4T.4 microglia exhibited less O 2 ⅐ Ϫ production in the presence of PMA (13.3 Ϯ 1.3-fold increase at 10 min). However, this activation in O 2 ⅐ Ϫ production was also suppressed by inhibition of NHE-1 activity. Together, these data further support our view that blocking NHE-1 activity in microglia decreases NOX activity and O 2 ⅐ Ϫ production.
Induction of cytokines and effector molecules after LPS or OGD/REOX treatment
We next investigated whether inhibition of NHE-1 activity can reduce mRNA expression of proinflammatory cytokines, which are markers of microglial activation: IL-1␤, TNF-␣, IL-6, and NOS2. As shown in Figure 7 , microglia treated with LPS (500 HOE 642 (d) . Arrow, Diffused DHE staining; arrowhead, increased DHE staining primarily localized to the nucleus. All images were collected using identical acquisition parameters. Scale bar, 15 m. B, Superoxide production was determined using the Diogenes kit under normoxic conditions or after 2 h OGD and 60 min REOX. HOE 642 (1.0 M) was present only during REOX to selectively inhibit NHE-1 activity. RLU per microgram values were expressed. Data are mean Ϯ SEM. n ϭ 3. *p Ͻ 0.05 versus normoxia; # p Ͻ 0.05 versus OGD/REOX. C, PMA-mediated superoxide production was determined at 1, 5, and 10 min after stimulation with 100 nM PMA. In the HOE 642 experiments, 1.0 M HOE 642 was added 20 min before and throughout the PMA exposure. RLU per micrograms per seconds values were normalized to the untreated values and expressed as relative change. Data are mean Ϯ SEM. n ϭ 3-6. *p Ͻ 0.05 versus 0 min; # p Ͻ 0.05 versus PMA alone. ng/ml) for 24 h triggered an ϳ20-fold increase in IL-1␤ mRNA, approximately fivefold increase in IL-6 mRNA, approximately fivefold increase in TNF-␣ mRNA, and approximately sixfold increase in NOS2 mRNA expression. These results are similar to those observed previously with LPS stimulation of primary microglia cultures (Olson and Miller, 2004) . With NHE-1 inhibition, the LPS-mediated elevation of these proinflammatory cytokine mRNAs was abolished. After the OGD/REOX treatment, microglial mRNA expression of IL-1␤, TNF-␣, IL-6, and NOS2 was significantly upregulated by approximately ninefold, approximately fourfold, approximately fourfold, and approximately twofold, respectively. Blocking NHE-1 activity with HOE 642 (1 M) attenuated the OGD/REOX-mediated mRNA expression of IL-1␤, TNF-␣, IL-6, and NOS2 (Fig. 7) . These data suggest that LPS and OGD/REOX treatments trigger microglial proinflammatory responses and NHE-1 function plays a role in this process.
Next, we investigated changes in the secretion of proinflammatory cytokines (IL-1␤, IL-6, and TNF-␣) in M4T.4 after stimulation with LPS or OGD/REOX (Fig. 8) . LPS treatment of M4T.4 microglia (500 ng/ml for 24 h) increased IL-1␤, IL-6, and TNF-␣ levels by approximately sevenfold, approximately threefold, and approximately threefold, respectively. OGD/REOX triggered an approximately eightfold increase in IL-1␤ level, approximately fourfold increase in IL-6 level, and approximately twofold increase in TNF-␣ level (Fig. 8) . Similarly, primary microglia also exhibited LPS-mediated cytokine release (approximately twofold, approximately fivefold, and approximately twofold increased release of IL-1␤, IL-6, and TNF-␣, respectively). In primary microglia, OGD/REOX led to approximately threefold, approximately fivefold, and approximately threefold increase in generation of these cytokines, respectively (Fig. 9) . Interestingly, blocking NHE-1 activity with HOE 642 (1 M) significantly attenuated the OGD/REOX and LPS-mediated production of these proinflammatory cytokines in both M4T.4 (Fig.  8 ) and primary microglia (Fig. 9) . Conversely, no changes were observed in the anti-inflammatory IL-10 expression after OGD/ REOX and LPS treatments (data not shown).
IL-1β
Figure 7. Inhibition of NHE-1 activity reduces cytokines and NOS2 mRNA levels in activated microglia. Expression of mRNA for innate immune cytokines and NOS2 was determined in M4T.4 cells after either 24 h LPS treatment (500 ng/ml) or 24 h REOX after 2 h OGD. HOE 642 at 1 M was present during 24 h LPS or REOX treatment. Real-time PCR was conducted with primers specific for IL-1␤, IL-6, TNF-␣, or NOS2. The mRNA expression was measured in femtograms after normalization and based on a standard curve for each primer pair. Relative changes in mRNAs are shown. Data are mean Ϯ SD. n ϭ 3. *p Ͻ 0.05 versus normoxic control; # p Ͻ 0.05 versus LPS treatment; ␣ p Ͻ 0.05 versus OGD/REOX. 
